Orthofix CLO sells shares to cover RSU taxes

Orthofix Medical Inc. CLO Jorge Andres Cedron reported an open-market sale of 3,743 shares of common stock at $12.82 per share on April 16, 2026.

Rhea-AI Filing Summary

Orthofix Medical Inc. CLO Jorge Andres Cedron reported an open-market sale of 3,743 shares of common stock at $12.82 per share on April 16, 2026. According to the footnote, these shares were sold solely to satisfy tax withholding obligations tied to the settlement of restricted stock units under a pre-existing, Compensation and Talent Development Committee–mandated sell-to-cover requirement, leaving the executive with 59,006 shares, including 44,353 previously reported restricted stock units. The sale was made without any exercise of discretion by the reporting person.

Insider Trade Summary

Net Seller: 3,743 shares

Net Sell 1 txn

Insider Cedron Jorge Andres

Role CLO

Sold 3,743 shs ($48K)

Type	Security	Shares	Price	Value
Sale	Common Stock	3,743	$12.82	$48K

Holdings After Transaction: Common Stock — 59,006 shares (Direct)

Footnotes (2)

1. F1. Represents the number of shares of common stock sold to satisfy tax withholding obligations in connection with the settlement of restricted stock units, pursuant to a pre-existing sell-to-cover requirement previously approved and mandated by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). Such sale was made without the exercise of any discretion by the reporting person.
2. F2. Includes 44,353 previously reported restricted stock units.

Key Figures

Shares sold: 3,743 shares Sale price: $12.82 per share Shares held after transaction: 59,006 shares +1 more

4 metrics

Shares sold 3,743 shares Open-market sale on April 16, 2026

Sale price $12.82 per share Price for 3,743 sold shares

Shares held after transaction 59,006 shares Direct holdings following the sale

Restricted stock units included 44,353 RSUs Previously reported RSUs included in post-transaction holdings

Key Terms

restricted stock units, sell-to-cover requirement, tax withholding obligations, Compensation and Talent Development Committee

4 terms

restricted stock units financial

"in connection with the settlement of restricted stock units, pursuant to a pre-existing sell-to-cover requirement"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

sell-to-cover requirement financial

"pursuant to a pre-existing sell-to-cover requirement previously approved and mandated by the Compensation and Talent Development Committee"

tax withholding obligations financial

"shares of common stock sold to satisfy tax withholding obligations in connection with the settlement of restricted stock units"

Compensation and Talent Development Committee financial

"previously approved and mandated by the Compensation and Talent Development Committee of the Company's Board of Directors"

FAQ

What insider transaction did Orthofix Medical (OFIX) disclose for Jorge Andres Cedron?

Orthofix Medical reported that CLO Jorge Andres Cedron sold 3,743 shares of common stock at $12.82 per share. The transaction occurred on April 16, 2026 and was linked to tax withholding needs from restricted stock unit settlement, not a discretionary open-market sale.

Why did Orthofix Medical (OFIX) CLO Cedron sell 3,743 shares?

The 3,743 shares were sold solely to cover tax withholding obligations arising from the settlement of restricted stock units. The sale followed a pre-existing sell-to-cover requirement approved by the Compensation and Talent Development Committee and was executed without any discretionary decision by Cedron.

How many Orthofix Medical (OFIX) shares does Cedron hold after this Form 4 transaction?

After the sale, Cedron holds 59,006 shares of Orthofix Medical common stock directly. This total includes 44,353 previously reported restricted stock units, showing that the tax-related sale affected only a small portion of his overall equity-based position.

Was the Orthofix Medical (OFIX) insider sale part of a trading plan?

The filing states the sale was pursuant to a pre-existing sell-to-cover requirement mandated by the Compensation and Talent Development Committee. This arrangement automatically sold shares to satisfy tax withholding on restricted stock unit settlement, without discretionary timing decisions by the reporting person.

What price did Orthofix Medical (OFIX) insider Cedron receive for the sold shares?

Cedron’s 3,743 Orthofix Medical shares were sold at $12.82 per share. The transaction was described as an open-market or private sale used strictly to fund tax withholding obligations associated with restricted stock units, rather than a discretionary portfolio management trade.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/20/2026 - 04:11 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Cedron Jorge Andres

(Last) (First) (Middle)

3451 PLANO PARKWAY

(Street)

LEWISVILLE TEXAS 75056

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Orthofix Medical Inc. [ OFIX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CLO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/16/2026		S(1)		3,743	D	$12.82	59,006(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the number of shares of common stock sold to satisfy tax withholding obligations in connection with the settlement of restricted stock units, pursuant to a pre-existing sell-to-cover requirement previously approved and mandated by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). Such sale was made without the exercise of any discretion by the reporting person.

2. Includes 44,353 previously reported restricted stock units.

	/s/ Jorge Andres Cedron	04/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)